Advances in patent applications related to cancer vaccine using CpG-ODN and OX40 association-Reference-Cited by-同舟云学术

Advances in patent applications related to cancer vaccine using CpG-ODN and OX40 association

Published:2020-02-10 Issue:4 Volume:30 Page:287-301
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Quintella Cristina M¹²^ORCID,Quintella Heitor M³^ORCID,Rohweder Mayla¹²⁴^ORCID,Quintella Guilherme M¹²⁵^ORCID

Affiliation:

1. Chemistry Institute, Federal University of Bahia, Campus Universitário de Ondina, Salvador, BA, Brasil

2. Medicine School, Federal University of Minas Gerais, Belo Horizonte, MG, Brasil

3. PROFNIT - Postgraduate Program on Intellectual Property and Technology Transfer for Innovation, Federal University of Bahia, Campus Universitário de Ondina, Salvador, BA, Brasil

4. CEPARH - Research and Assistance Center on Human Reproduction, Salvador, BA, Brazil

5. Quintellar Legal Consulting Company, Salvador, BA, Brazil

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2020.1724960

Reference54 articles.

1. Cancer immunotherapy: harnessing the immune system to battle cancer

2. Current advances in T-cell-based cancer immunotherapy

3. Enhancing Cancer Immunotherapy Via Activation of Innate Immunity

4. Pathogen Recognition and Innate Immunity

5. Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malaria transmission blocking activity of Anopheles stephensi alanyl aminopeptidase N antigen formulated with MPL, CpG, and QS21 adjuvants;PLOS ONE;2024-07-05

2. Technologie-Reifegradbewertung im Gesundheitswesen – Eine bibliometrische Analyse;Technologien und Technologiemanagement im Gesundheitswesen;2024

3. Altering Landscape of Cancer Vaccines: Unique Platforms, Research on Therapeutic Applications and Recent Patents;Recent Patents on Anti-Cancer Drug Discovery;2023-05

4. Anti-tumour effect of in situ vaccines combined with VEGFR inhibitors in the treatment of metastatic cervical cancer;International Immunopharmacology;2021-12